Esophagus : official journal of the Japan Esophageal SocietyHumansAntibodiesMonoclonalHumanizedMale
Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29).
Min Hee Hong, Sung Kwan Shin, Su-Jin Choi, Beung-Chul Ahn, Hye Ryun Kim, Seong Yong Park, Dae Joon Kim, Chang Geol Lee, Jaeho Cho, Jong Hoon Kim, Hyeong Ryul Kim, Yong-Hee Kim, Gang-Taik Lee, Sook Ryun Park, Sang Kil Lee
Published: 202610.1007/s10388-025-01165-0
Abstract
BACKGROUND: Neoadjuvant chemoradiotherapy (NCRT) followed by surgery is a standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, the survival outcomes remain suboptimal. Immune checkpoint inhibitors have shown pro…
Preview only. Read the full abstract at the source